These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11477319)

  • 41. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T; Sorri A; Moilanen E; Ylitalo P
    Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
    Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.
    Sigaroudi A; Kullak-Ublick GA; Weiler S
    Eur J Clin Pharmacol; 2016 Mar; 72(3):377-8. PubMed ID: 26631062
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.
    Clinckers R; Smolders I; Michotte Y; Ebinger G; Danhof M; Voskuyl RA; Della Pasqua O
    Br J Pharmacol; 2008 Dec; 155(7):1127-38. PubMed ID: 18836479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
    Clemens PL; Cloyd JC; Kriel RL; Remmel RP
    Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxcarbazepine in infants and young children with partial seizures.
    Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y
    Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.
    Schmutz M; Brugger F; Gentsch C; McLean MJ; Olpe HR
    Epilepsia; 1994; 35 Suppl 5():S47-50. PubMed ID: 8039471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
    Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
    Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe overdosage with the antiepileptic drug oxcarbazepine.
    van Opstal JM; Janknegt R; Cilissen J; L'Ortije WH; Nel JE; De Heer F
    Br J Clin Pharmacol; 2004 Sep; 58(3):329-31. PubMed ID: 15327594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formation of active metabolites of anticonvulsant drugs. A review of their pharmacokinetic and therapeutic significance.
    Eadie MJ
    Clin Pharmacokinet; 1991 Jul; 21(1):27-41. PubMed ID: 1914340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
    Christensen J; Sabers A; Sidenius P
    Neurology; 2006 Oct; 67(8):1497-9. PubMed ID: 17060586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of valproic acid on the pharmacokinetic profile of oxcarbazepine in the rat.
    Matar KM; Nicholls PJ; Bawazir SA; al-Hassan MI; Tekle A
    Pharm Acta Helv; 1999 Feb; 73(5):247-50. PubMed ID: 10085790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.
    Baruzzi A; Albani F; Riva R
    Epilepsia; 1994; 35 Suppl 3():S14-9. PubMed ID: 8156974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS.
    Chen X; Gu E; Wang S; Zheng X; Chen M; Wang L; Hu G; Cai JP; Zhou H
    J Chromatogr Sci; 2016 Mar; 54(3):334-42. PubMed ID: 26499119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients.
    May TW; Rambeck B; Sälke-Kellermann A
    Acta Neurol Scand; 1996 Jun; 93(6):393-7. PubMed ID: 8836299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.